A RANDOMIZED, MULTICENTER, OPEN-LABEL CLINICAL TRIAL TO ASSESS THE ANAMNESTIC IMMUNE RESPONSE 4 TO 8 YEARS AFTER A PRIMARY HEPATITIS B VACCINATION SERIES
Por:
Diez-Domingo J, Flores SA, Martin JC, Klopfer SO, Schödel FP and Bhuyan PK
Publicada:
1 oct 2010
Resumen:
This open-label, randomized study challenged 4- to 8-year-old children from Spain (N = 1478) with a single dose of hepatitis B vaccine to estimate anamnestic responses. At the time of preimmunization, 15.9% to 51.2% of subjects had antibody values >= 10 mIU/mL. One month postimmunization, 91.6% to 97.3% of subjects had antibody titers >= 10 mIU/mL. There were no serious, vaccine-related, adverse experiences, and no discontinuations as a result of adverse experience.
Bronze
|